If you wish to speak with The Conafay Group, please contact Steve Wasserman (ssw3an).
The Department of Defense has released the following FY18 funding opportunities for its Psychological Health/Traumatic Brain Injury Research Program (PH/TBIRP) being managed by the office of Congressionally Directed Medical Research Programs (CDMRP).
TBI is defined as being caused by (1) a direct blow or impact to the head, (2) a penetrating head
injury, or (3) an exposure to external forces such as blast waves that disrupt the function of the
brain. Not all blows to the head or exposure to external forces result in a TBI. The severity of
TBI may range from “mild,” a brief change in mental status or consciousness, to “severe,” an
extended period of unconsciousness or confusion after the injury. Classification of TBI severity
can be found in Table 1 of the VA/DoD Clinical Practice Guideline for the Management of
Concussion-Mild Traumatic Brain Injury.
- The anticipated total (direct + indirect) costs budgeted for the entire period of performance for an FY18 PH/TBIRP CTRR-CRA will not exceed $2.0 million (M). Refer to Section II.D.5, Funding Restrictions, for detailed funding information.
- Supports clinical research but not clinical trials. Supported research can include pre-clinical studies using human subjects or samples and observational or mechanistic clinical research studies.
- Applications must include preliminary data and/or published data from the literature that are relevant to complex TBI and support the rationale for the proposed research project.
- The anticipated total (direct and indirect) costs budgeted for the entire period of performance for an FY18 PH/TBIRP CTRR-CTA will not exceed $2.0 million (M).
- A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g., device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention, or other) is tested on a human subject for a measurable outcome with respect to safety, effectiveness, and/or efficacy.
- The anticipated total (direct and indirect) costs budgeted for the entire period of performance for
an FY18 PH/TBIRP CTRR-CTDA will not exceed $200,000. Refer to Section II.D.5, Funding
Restrictions, for detailed funding information.
- Investigators awarded a PH/TBIRP CTRR-CTDA are expected to apply to the PH/TBIRP
CTRR-Clinical Trial Award in the program year following completion of their CTDA.
Deadlines for all three programs: Pre-Application September 24, 2018; Application December 17, 2018
Detailed descriptions of the funding opportunity, evaluation criteria, and submission requirements can be found in the Program Announcements. The Program Announcements are available electronically for downloading from the Grants.gov website (http://www.grants.gov), the CDMRP website (http://cdmrp.army.mil/funding/prgdefault.shtml), and the electronic Biomedical Research Application Portal (eBRAP) (https://eBRAP.org).
All CDMRP funding opportunities, both recently and previously released, are available on the CDMRP website (http://cdmrp.army.mil).
Subsequent notifications will be sent when additional funding opportunities are released. A listing of all open CDMRP funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
Submission is a two-step process requiring both pre-application submission and full application submission. All pre-applications must be submitted through eBRAP (https://eBRAP.org/). Full applications from extramural organizations (non-DoD organizations) must be submitted through Grants.gov (http://www.grants.gov/). Intramural DoD organizations may submit full applications to either eBRAP or Grants.gov. Refer to the General Application Instructions, Section II.A. for registration and submission requirements for eBRAP and Grants.gov. For detailed information on the submission process, refer to Section II.D. of the Program Announcement/Funding Opportunity.
eBRAP is a multifunctional web-based system that allows PIs to submit their pre-applications electronically through a secure connection, to view and edit the content of their pre-applications and full applications, to receive communications from the CDMRP, and to submit documentation during award negotiations and period of performance. A key feature of eBRAP is the ability of an organization’s representatives and PIs to view and modify the Grants.gov application submissions associated with them. eBRAP will validate Grants.gov application files against the specific Program Announcement/Funding Opportunity requirements and discrepancies will be noted in an email to the PI and in the Full Application Files tab in eBRAP. It is the applicant’s responsibility to review all application components for accuracy as well as ensure proper ordering as specified in this Program Announcement/Funding Opportunity.
Filed Under: Funding Opportunities